The BMI Project (Body, Mind, Inflammation)
A Novel Integrated Lifestyle Intervention to Reduce Obesity and Inflammation Among Emerging Adults
3 other identifiers
interventional
19
1 country
1
Brief Summary
Obesity and chronic inflammation influence the development and progression of many types of cancer. These conditions share several of the same causes, including physical inactivity, poor nutrition, stress, and insufficient sleep. Emerging adulthood (ages 18-25) represents an important developmental period in which to address behaviors and psychological variables that affect both weight status and inflammation. At least 40% of emerging adults have overweight/obesity, and this transition from adolescence to early adulthood is associated with significant increases in fast food consumption, decreases in physical activity, unpredictable sleep schedules, and alarmingly high rates of depression and perceived stress. Despite this high risk for obesity, very few weight loss interventions are designed specifically for emerging adults. Preliminary findings from weight loss interventions targeting this population have shown some promise, but generally produce modest outcomes with less consistent effects than programs in older adults. Depression and stress have been found to interfere with weight loss among emerging adults, and may be in part responsible for poorer outcomes. This proposal will develop and test an Integrated Lifestyle Intervention (ILI) that comprehensively addresses both psychological distress and traditional weight management targets. This novel approach has not been tested before and has the potential not only to enhance weight loss outcomes in this high risk population, but also to produce reductions in markers of inflammation beyond those achievable by weight loss alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2019
CompletedStudy Start
First participant enrolled
July 15, 2019
CompletedFirst Posted
Study publicly available on registry
July 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2021
CompletedMay 11, 2022
May 1, 2022
1.9 years
July 15, 2019
May 5, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Number of sessions attended throughout the intervention period
Attendance at in-person treatment sessions is one critical metric for demonstrating feasibility and will be tracked throughout the intervention period.
4 months
Number of days self-monitoring weight in LoseIt
Self-monitoring of weight is a critical metric for demonstrating feasibility and will be tracked throughout the intervention period.
4 months
Number of days self-monitoring weight-related behaviors in LoseIt
Self-monitoring of weight-related behaviors (e.g., diet and physical activity) is a critical metric for demonstrating feasibility and will be tracked throughout the intervention period.
4 months
Secondary Outcomes (4)
Change in diet
Baseline and 4 months
Change in physical activity
Baseline and 4 months
Change in sleep
Baseline and 4 months
Percent Weight Change
Baseline and 4 months
Study Arms (1)
Integrated Lifestyle Intervention
EXPERIMENTALInterventions
This program is grounded in data demonstrating the dysregulation across multiple domains and considerable life stressors experienced by this population. The central hypothesis is that by simultaneously ameliorating psychological dysregulation and directly targeting proinflammatory behaviors, ILI operates on multiple proposed mediators of poor treatment outcomes in this population, thereby enhancing treatment outcomes. As such, the overall framework emphasizes integration of self-regulation as it applies to both psychological functioning and weight control. Content will highlight the interconnectedness of mood, stress, eating and exercise behaviors, and risk for inflammation and disease. Each treatment session will present a combination of behavioral and psychological content, representing a truly integrated approach. Participants will meet for 75-minute group sessions weekly for months 1-2, followed by bi-weekly groups in months 3-4, for a total of 12 groups.
Eligibility Criteria
You may qualify if:
- Age between 18 and 25 years
- Body Mass Index between 25 and 45 kg/m2
You may not qualify if:
- Currently pregnant or lactating; pregnancy in the last 6 months or plans to become pregnant in the next 6 months
- Type 1 or type 2 diabetes
- Any uncontrolled medical conditions that could make it unsafe to participate in unsupervised exercise
- Medical conditions associated with chronic inflammation
- Inability to read, understand and speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica LaRose, PhD
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2019
First Posted
July 17, 2019
Study Start
July 15, 2019
Primary Completion
June 18, 2021
Study Completion
June 18, 2021
Last Updated
May 11, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share